Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY G9013-G9140 (Medicare Demonstration Projects)

2025 HCPCS code G9106

Provides information on the disease status of pancreatic cancer (adenocarcinoma) post-R1 or R2 resection, with no disease progression or metastases; used in a Medicare-approved demonstration project.

2025 HCPCS code G9116

This HCPCS code reports information on the disease status of ovarian epithelial cancer (progressive, recurrent, or platinum-resistant) as part of a 2006 Medicare demonstration project.

2025 HCPCS code G9057

Reports that patient management deviates from guidelines due to IRB-approved clinical trial enrollment; used in a Medicare demonstration project.

2025 HCPCS code G9139

Provides information about chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome or BCR-ABL gene, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9114

This HCPCS code reports the disease status of ovarian cancer (epithelial, stages IA-B, or IC), specifically within the context of a past Medicare demonstration project (2006).

2025 HCPCS code G9124

This HCPCS code reports information about chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome or BCR-ABL gene, in the accelerated phase and not in remission.

2025 HCPCS code G9138

Provides information on the disease status of non-Hodgkin's lymphoma undergoing evaluation for response to therapy or recurrence, with the current stage unverified.Used as part of a 2006 Medicare demonstration project.

2025 HCPCS code G9101

Provides information on the disease status of gastric adenocarcinoma, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9075

Reports information on the disease status of a patient's invasive female breast cancer (adenocarcinoma, M1 stage at diagnosis, metastatic, locally recurrent, or progressive; excludes ductal carcinoma origin).

2025 HCPCS code G9050

This HCPCS code reports the primary focus of an evaluation and management (E/M) visit for a cancer patient, including work-up, evaluation, or staging at diagnosis or recurrence.

2025 HCPCS code G9077

Reports information on prostate cancer disease status for a Medicare-approved demonstration project.

2025 HCPCS code G9058

Reports that patient management differs from practice guidelines due to provider disagreement with recommendations; used in a Medicare demonstration project.

2025 HCPCS code G9062

Indicates the management of the patient differs from established oncology practice guidelines for reasons not otherwise specified.

2025 HCPCS code G9133

G9133 reports the disease status of hormone-responsive prostate adenocarcinoma with metastases, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9140

Covers a stay of four or more hours in a CMS-approved Frontier Extended Stay Clinic (FESC) for seriously ill patients unable to transfer to an acute care hospital due to extenuating circumstances.